3 Feb 2023
Huntington’s metabolic dysfunctions – PhD interview with Elna Dickson
Huntington's disease is known as the "dance disease" due to the patient's characteristic motor symptoms. However, Elna Dickson's Ph.D. project shows that the disease also leads to ...
13 Jan 2023
Cognitive disease beyond the brain – PhD interview with Keivan Javanshiri
Keivan Javanshiri’s Ph.D. project explores cardiac and vascular pathologies in Lewy body dementia and Alzheimer's disease. January 20, he defends his thesis. Here, he shares the mo...
12 Jan 2023
Nerve cells could transform the treatment of Parkinson’s
At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disea...
10 Jan 2023
Why dopamine receptor type matters – PhD interview with Katrine Skovgård
Katrine Skovgård’s Ph.D. project sheds light on the dysfunctions in the brain through which dopaminergic pharmacotherapies for Parkinson’s disease affect motor behaviors. January 1...
3 Jan 2023
Optimal blood tests for development of new therapies of Alzheimer’s disease
A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting releva...
21 Dec 2022
MultiPark – Closing the circle of 2022 and looking forward to 2023
We ended the MultiPark year in December as we started it in January: with a MultiPark Retreat! The December retreat was our first big meeting IRL after the pandemic, and it turned ...
14 Dec 2022
Molecular signaling in neurodegenerative disorders – A special interest group
MultiPark’s new special interest groups (SIGs) address essential scientific and technological needs and provide opportunities for professional development and network formation to ...
8 Dec 2022
Nobel Prize winner Arvid Carlsson – 7 things you perhaps did not know about him and his research
2 Dec 2022
Walking with neurodegeneration – PhD interview with Magnus Lindh-Rengifo
Walking is probably more cognitively demanding than you think. Magnus Lindh-Rengifo defends his thesis about walking aspects in neurodegenerative disorders on December 16. Read abo...
29 Nov 2022
The brain's immune cells can be triggered to slow down Alzheimer's disease
The brain's big-eating immune cells can slow down the progression of Alzheimer's disease. This is shown by a study that is now published in Nature Aging.
23 Nov 2022
The glymphatic system in PD – PhD interview with Roberta Battistella
The glymphatic system clears waste products from the brain. Roberta Battistella defends her thesis about the role of this system in Parkinson’s disease on December 1. Here, she tel...
22 Nov 2022
Brain Circuit Analysis – A special interest group
MultiPark’s backbone for research interactions is about to be reorganized. The 13 new special interest groups (SIGs) address essential scientific and technological needs and provid...
17 Nov 2022
Alzheimer's disease can be diagnosed before symptoms emerge
A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any symptoms. It is now also possible to ...
7 Nov 2022
MultiPark researcher with Bill Gates in Brussels
MultiPark’s scientists conduct world-leading research in biomarkers for Alzheimer’s disease, led by Professor Oskar Hansson at the memory clinic at Skåne University Hospital. He re...
28 Oct 2022
Modelling Parkinson’s disease – PhD interview with Matilde Negrini
Matilde Negrini’s thesis project has been to develop and characterize a rat model of Parkinson’s disease. November 4, she defends her thesis. Here, she talks about her project and ...
24 Oct 2022
Does the Mediterranean diet really decrease your risk of dementia?
Numerous studies have suggested that eating a healthy diet may reduce a person’s risk of dementia. A new study from one of MultiPark's research groups, published in Neurology, shed...
21 Oct 2022
Swedish Medical Products Agency grants approval for clinical study of new stem cell based Parkinson’s Disease treatment
An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval ...
7 Oct 2022
Turning glia into neurons inside the brain – PhD interview with Jessica Giacomoni
Cell replacement therapy has long been a hope for patients with Parkinson’s disease and efforts are on their way to use stem cell derived-dopaminergic neurons in clinical trials. O...
5 Oct 2022
Biomarker reveals inflammatory changes in the brain with Alzheimer’s disease
Inflammatory responses in the brain have long been suspected of playing a role in Alzheimer’s disease, but are challenging to monitor in the living human brain. An international co...
28 Sep 2022
Malin Parmar elected to the Royal Swedish Academy of Sciences
The Royal Swedish Academy of Sciences has elected two new members of the Academy’s class for medical sciences. One of them is Malin Parmar, Professor of Cellular Neuroscience at Lu...